BEUDAMED
    10 results · 18ms · Sources: EU EUDAMED, US FDA

    Get notified when this changes

    We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.
    Filters Regulation: Us FDA ×

    MINOR LACERATION TRAY W/ INSTRUMENT, STERILE, DISP

    FDA 510(k)
    FDA Class 2 ·General, Plastic Surgery

    Instrument Case

    FDA UDI
    KATENA PRODUCTS, INC.·00841668110928·STERILIZING CASE SINGLE VR

    Accu-Beam

    FDA UDI
    TRANSAMERICAN TECHNOLOGIES INTERNATIONAL·B1779205170·Re-usable fiberoptic handpiece for lasers. 17ga...

    DEPUY PULSE CERVICAL CAGE SYSTEM

    FDA 510(k)
    FDA Class 2 ·Orthopedic

    SYNTHES DUAL-OPENING USS

    FDA 510(k)
    FDA Class 2 ·Orthopedic

    FENESTRATED BIPOLAR FORCEPS

    FDA Adverse Event
    Malfunction ·INTUITIVE SURGICAL,INC.·Product code NAY·January 17, 2013

    ENDO CLIP 5MM CLIP APPLIER

    FDA Adverse Event
    Injury ·UNITED STATES SURGICAL·Product code FZP·December 6, 2010

    ACCENT DR

    FDA Adverse Event
    Injury ·ST. JUDE MEDICAL, INC., CRMD·Product code DXY·July 8, 2014

    BioGX SARS-CoV-2 Reagents for BD MAX System Catalog number (REF) 444213. In vitro diagnostic. SARS-CoV-2 Reagents is a real-time RT-PCR test intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in nasopharyngeal, nasal, mid-turbinate, and oropharyngeal swab specimens, nasopharyngeal wash/aspirate or nasal aspirates obtained from individuals suspected of COVID-19 by their healthcare provider.

    FDA Enforcement
    Class II ·Terminated·Becton Dickinson & Co.·February 17, 2021

    BioGX SARS-CoV-2 Reagents for BD MAX System-IVD PCR test intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in nasopharyngeal specimens Catalog Number: 444213

    FDA Enforcement
    Class II ·Terminated·Becton Dickinson & Co.·April 21, 2021